5E6-15781-20486

1 vaccination 15 coded responses 15 check-ins 15 free-text entries 14 call cases

Sex: Male
Age at first dose: 26-30
ZIP prefix: 981 / WA
Registered: 2021-11-12

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-11
Dose 1 — Pfizer-BioNTech
2021-11-12
Registered in v-safe
2021-11-12
Survey response — days 1–6 daily, dose 1
MedDRA: Tinnitus — Feeling: Poor · Site: Pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Severe ringing in my ears/tinnitus

MedDRA releases: 2024-11 · check-in free text available
2021-11-12
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-13
Survey response — days 1–6 daily, dose 1
MedDRA: Tinnitus — Feeling: Poor · Site: Pain · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Severe tinnitus, not getting better

MedDRA releases: 2024-11 · check-in free text available
2021-11-13
Report sent to call center — days 1–6 daily, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-11-14
Survey response — days 1–6 daily, dose 1
MedDRA: Tinnitus, Unevaluable event — Feeling: Poor · Site: Pain · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Systemic reaction (other): Severe tinnitus. Not improving. · Healthcare visit (other): Appointment scheduled to see specialist

MedDRA releases: 2024-11 · check-in free text available
2021-11-14
Report sent to call center — days 1–6 daily, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-15
Survey response — days 1–6 daily, dose 1
MedDRA: Adverse reaction, Deafness, Tinnitus — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Systemic reaction (other): Severe tinnitus, hearing loss · Healthcare visit (other): Moved up appointment with specialist due to severity

MedDRA releases: 2024-11 · check-in free text available
2021-11-15
Report sent to call center — days 1–6 daily, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-11-16
Survey response — days 1–6 daily, dose 1
MedDRA: Tinnitus — Feeling: Poor · Headache · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Severe constant tinnitus

MedDRA releases: 2024-11 · check-in free text available
2021-11-16
Report sent to call center — days 1–6 daily, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-16
Call 1 — Could Not Reach Participant
2021-11-17
Survey response — days 1–6 daily, dose 1
MedDRA: Tinnitus — Feeling: Poor · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Severe tinnitus

MedDRA releases: 2024-11 · check-in free text available
2021-11-17
Report sent to call center — days 1–6 daily, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-17
Call 1 — Could Not Reach Participant
2021-11-18
Survey response — day 7, dose 1
MedDRA: Audiogram abnormal, Office visit, Tinnitus — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Systemic reaction (other): Severe tinnitus, potential hearing loss per audiogram · Healthcare visit (other): Audiogram and second ent consult

MedDRA releases: 2024-11 · check-in free text available
2021-11-18
Report sent to call center — day 7, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-18
Call 1 — Could Not Reach Participant
2021-11-19
Call 1 — Could Not Reach Participant
2021-11-25
Survey response — day 14, dose 1
MedDRA: Hypoacusis, Office visit, Tinnitus — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Severe tinnitus and some hearing loss · Healthcare visit (other): Audiologist appointment and hearing test

MedDRA releases: 2024-11 · check-in free text available
2021-11-25
Report sent to call center — day 14, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-28
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-12-02
Survey response — day 21, dose 1
MedDRA: Office visit, Tinnitus — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Worsening tinnitus · Healthcare visit (other): Hearing test at audiologist

MedDRA releases: 2024-11 · check-in free text available
2021-12-02
Report sent to call center — day 21, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-12-03
Call 1 — Could Not Reach Participant
2021-12-08
Call 2 — Could Not Reach Participant
2021-12-09
Survey response — day 28, dose 1
MedDRA: Tinnitus — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Severe tinnitus

MedDRA releases: 2024-11 · check-in free text available
2021-12-09
Report sent to call center — day 28, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-12-10
Call 1 — Could Not Reach Participant
2021-12-16
Survey response — day 35, dose 1
MedDRA: Tinnitus — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Severe tinnitus

MedDRA releases: 2024-11 · check-in free text available
2021-12-16
Report sent to call center — day 35, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-12-17
Call 1 — Could Not Reach Participant
2021-12-22
Call 2 — Could Not Reach Participant
2021-12-23
Survey response — day 42, dose 1
MedDRA: Tinnitus — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Severe tinnitus, worsening.

MedDRA releases: 2024-11 · check-in free text available
2021-12-23
Report sent to call center — day 42, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-12-27
Call 1 — Left Voicemail
2022-01-13
Call 1 — Left Voicemail
2022-02-10
Survey response — 3 months, dose 1
MedDRA: Tinnitus — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Worsening bilateral tinnitus

MedDRA releases: 2024-11 · check-in free text available
2022-02-10
Report sent to call center — 3 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-11
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2022-05-12
Survey response — 6 months, dose 1
MedDRA: Deafness, Tinnitus — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Tinnitus and hearing loss

MedDRA releases: 2024-11 · check-in free text available
2022-05-12
Report sent to call center — 6 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-13
Call 1 — Left Voicemail
2022-11-11
Survey response — 12 months, dose 1
MedDRA: Deafness, Tinnitus — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Tinnitus, hearing loss

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-11	Pfizer-BioNTech	No

Call center

14 call center cases

10 successful · 4 unsuccessful

VAERS report filed, before or during a call: 11

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 1

2021-11-12

Systemic reaction (other): Severe ringing in my ears/tinnitus

2021-11-13

Systemic reaction (other): Severe tinnitus, not getting better

2021-11-14

Systemic reaction (other): Severe tinnitus. Not improving.

Healthcare visit (other): Appointment scheduled to see specialist

2021-11-15

Systemic reaction (other): Severe tinnitus, hearing loss

Healthcare visit (other): Moved up appointment with specialist due to severity

2021-11-16

Systemic reaction (other): Severe constant tinnitus

2021-11-17

Systemic reaction (other): Severe tinnitus

Release 10 — day 7, dose 1

2021-11-18

Systemic reaction (other): Severe tinnitus, potential hearing loss per audiogram

Healthcare visit (other): Audiogram and second ent consult

Release 10 — day 14, dose 1

2021-11-25

Symptoms: Severe tinnitus and some hearing loss

Healthcare visit (other): Audiologist appointment and hearing test

Release 10 — day 21, dose 1

2021-12-02

Symptoms: Worsening tinnitus

Healthcare visit (other): Hearing test at audiologist

Release 10 — day 28, dose 1

2021-12-09

Symptoms: Severe tinnitus

Release 10 — day 35, dose 1

2021-12-16

Symptoms: Severe tinnitus

Release 10 — day 42, dose 1

2021-12-23

Symptoms: Severe tinnitus, worsening.

Release 11 — 3 months, dose 1

2022-02-10

Symptoms: Worsening bilateral tinnitus

Release 11 — 6 months, dose 1

2022-05-12

Symptoms: Tinnitus and hearing loss

Release 12 — 12 months, dose 1

2022-11-11

Symptoms: Tinnitus, hearing loss

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Adverse reaction	·	·	✓
HCVO	Office visit	·	·	✓
HCVO	Unevaluable event	·	·	✓
SD	Deafness	·	·	✓
SD	Hypoacusis	·	·	✓
SD	Tinnitus	·	·	✓
SRO	Audiogram abnormal	·	·	✓
SRO	Deafness	·	·	✓
SRO	Tinnitus	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release